Monday, November 7, 2011
TTUHSC Awarded Nearly $6 Million in Research Funds
CPRIT grants will help five university faculty members continue cancer research.
Written by Suzanna Cisneros
Through their support of TTUHSC and other Texas universities, CPRIT helps seek breakthroughs for a devastating disease.
University researchers from multiple campuses have been awarded $5,693,296 in grant funds by the Cancer Prevention and Research Institute of Texas (CPRIT).
President Tedd L. Mitchell, M.D., said the new funds demonstrate the institution’s competitive research.
“Competition is fierce for CPRIT funding. Our faculty members have demonstrated their research programs can compete effectively at the state and national levels,” Mitchell said. “We congratulate them for their dedication to the type of research that seeks answers for combating this disease.”
Funds were awarded to:
- Richard Leff, Pharm.D., regional dean, School of Pharmacy at Dallas/Ft.Worth, $2.5 million
- Zeina Nahleh, M.D., Department of Internal Medicine, Paul L. Foster School of Medicine in El Paso, $1.5 million
- Magdalena Karbowniczek, M.D., Ph.D., School of Pharmacy at Abilene, $756,644
- Quentin R. Smith, Ph.D., professor and senior associate dean for sciences, School of Pharmacy at Amarillo, $736,685
- Ulrich Bickel, M.D., professor, School of Pharmacy at Amarillo, $199,967
Under its latest grant cycle, the institute is providing more than $100 million to Texas cancer research projects. Statewide, the institute has awarded more than $550 million in funding for cancer research, prevention and commercialization projects over the last two years.
“In the two short years that we have been investing in cancer research, drug development and prevention efforts in Texas, we continue to be impressed by the quality of the work being done around the state,” said Jimmy Mansour, founding chairman of the institute’s governing board. “The fact that this research is being done right here in our own state is a testament to the people of Texas who made a commitment to support the fight against this deadly disease.”
“The Cancer Prevention and Research Institute of Texas does an outstanding job furthering the battle against cancer, and we are very grateful for their continued support of our universities through these research grants,” Chancellor Kent Hance said. “To more than double the amount of state cancer research funding we’ve received since last year is remarkable.”
Competing for these awards remains a top strategic priority for the university system, and the Office of Research and Commercialization assists its universities in pursuing these external funding opportunities.
“Our faculty did a great job and we can do even better as we leverage our competitive advantage of being the only public institution in Texas with a health sciences and general academic university on the same campus,” Jodey Arrington, vice chancellor for research, commercialization and federal relations, said.
Cancer institute funding also is helping attract leading scientists in cancer research to Texas, as six CPRITScholar in Cancer Research recruitment awards were announced at the latest meeting.
Story produced by the Office of Communications and Marketing, (806) 743-2143.
CPRIT strives to expedite innovation and commercialization in the area of cancer research and to enhance access to evidence-based prevention programs and services throughout the state.
All CPRIT-funded research will be conducted in state by Texas-based scientists and reflect CPRIT’s mission to attract and expand the state’s research capabilities and create high quality new jobs in Texas.
Beginning in 1969 as Texas Tech University School of Medicine, TTUHSC now is a six-school university with campuses in Abilene, Amarillo, Dallas/Fort Worth, El Paso, Lubbock, Midland and Odessa.
TTUHSC has trained more than 20,000 health care professionals, and meets the health care needs of more than 2.5 million people in the 108 counties including those in the Texas Panhandle and eastern New Mexico.